Literature DB >> 18554297

Aberrant trafficking of the high-affinity choline transporter in AP-3-deficient mice.

Hidemi Misawa1, Hirofumi Fujigaya, Takashi Nishimura, Yasuhiro Moriwaki, Takashi Okuda, Koichiro Kawashima, Kazuko Nakata, Alicia M Ruggiero, Randy D Blakely, Fubito Nakatsu, Hiroshi Ohno.   

Abstract

The high-affinity choline transporter (CHT) is expressed in cholinergic neurons and efficiently transported to axon terminals where it controls the rate-limiting step in acetylcholine synthesis. Recent studies have shown that the majority of CHT is unexpectedly localized on synaptic vesicles (SV) rather than the presynaptic plasma membrane, establishing vesicular CHT trafficking as a basis for activity-dependent CHT regulation. Here, we analyse the intracellular distribution of CHT in the adaptor protein-3 (AP-3)-deficient mouse model mocha. In the mocha mouse, granular structures in cell bodies are intensely labelled with CHT antibody, indicating possible deficits in CHT trafficking from the cell body to the axon terminal. Western blot analyses reveal that CHT on SV in mocha mice is decreased by 30% compared with wild-type mice. However, no significant difference in synaptosomal choline uptake activity is detected, consistent with the existence of a large reservoir pool for CHT. To further characterize CHT trafficking, we established a PC12D-CHT cell line. In this line, CHT is found associated with a subpopulation of synaptophysin-positive synaptic-like microvesicles (SLMV). The amounts of CHT detected on SLMV are greatly reduced by treating the cell with agents that halt AP-dependent membrane trafficking. These results demonstrate that APs have important functions for CHT trafficking in neuronal cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18554297     DOI: 10.1111/j.1460-9568.2008.06268.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  5 in total

1.  Differential impact of genetically modulated choline transporter expression on the release of endogenous versus newly synthesized acetylcholine.

Authors:  Hideki Iwamoto; M Wade Calcutt; Randy D Blakely
Journal:  Neurochem Int       Date:  2016-03-22       Impact factor: 3.921

2.  Identification of a QTL in Mus musculus for alcohol preference, withdrawal, and Ap3m2 expression using integrative functional genomics and precision genetics.

Authors:  Jason A Bubier; Jeremy J Jay; Christopher L Baker; Susan E Bergeson; Hiroshi Ohno; Pamela Metten; John C Crabbe; Elissa J Chesler
Journal:  Genetics       Date:  2014-06-11       Impact factor: 4.562

3.  Nonoisotopic assay for the presynaptic choline transporter reveals capacity for allosteric modulation of choline uptake.

Authors:  Alicia M Ruggiero; Jane Wright; Shawn M Ferguson; Michelle Lewis; Katie S Emerson; Hideki Iwamoto; Michael T Ivy; Ericka C Holmstrand; Elizabeth A Ennis; C David Weaver; Randy D Blakely
Journal:  ACS Chem Neurosci       Date:  2012-07-09       Impact factor: 4.418

4.  Gene-expression changes in cerium chloride-induced injury of mouse hippocampus.

Authors:  Zhe Cheng; Haiquan Zhao; Yuguan Ze; Junju Su; Bing Li; Lei Sheng; Liyuan Zhu; Ning Guan; Suxin Gui; Xuezi Sang; Xiaoyang Zhao; Qingqing Sun; Ling Wang; Jie Cheng; Renping Hu; Fashui Hong
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

5.  Discovery of Compounds that Positively Modulate the High Affinity Choline Transporter.

Authors:  Parul Choudhary; Emma J Armstrong; Csilla C Jorgensen; Mary Piotrowski; Maria Barthmes; Rubben Torella; Sarah E Johnston; Yuya Maruyama; John S Janiszewski; R Ian Storer; Sarah E Skerratt; Caroline L Benn
Journal:  Front Mol Neurosci       Date:  2017-02-27       Impact factor: 5.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.